SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-101650
Filing Date
2024-04-19
Accepted
2024-04-19 07:30:29
Documents
8
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A d18791ddef14a.htm DEF 14A 392024
2 GRAPHIC g18791dsp047.jpg GRAPHIC 182684
3 GRAPHIC g18791dsp048.jpg GRAPHIC 128455
4 GRAPHIC g18791g02a02.jpg GRAPHIC 32126
5 GRAPHIC g18791g22b02.jpg GRAPHIC 52134
6 GRAPHIC g18791g38a01.jpg GRAPHIC 51441
7 GRAPHIC g18791g39a01.jpg GRAPHIC 82752
8 GRAPHIC g18791g45a45.jpg GRAPHIC 54601
  Complete submission text file 0001193125-24-101650.txt   1188762
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38529 | Film No.: 24855616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)